A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy

SAT0176 A Phase I Pharmacokinetic Study Comparing SB4, An Etanercept Biosimilar, and Etanercept Reference Product (Enbrel®) in Healthy Male Subjects: Table 1.

(2015) Y.J. Lee et al.   ANNALS OF THE RHEUMATIC DISEASES

OP0012 A Phase 3, Randomized, Double-Blind, Active Comparator Study of the Efficacy and Safety of Bow015, A Biosimilar Infliximab, in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses

(2014) J. Kay et al.   ANNALS OF THE RHEUMATIC DISEASES

Sustained Remission with Etanercept Tapering in Early Rheumatoid Arthritis

(2014) Paul Emery et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rheumatoid Arthritis Disease Progression Modeling

(2013) Russell Reeve et al.   Therapeutic Innovation & Regulatory Science

The role of biosimilars in the treatment of rheumatic diseases

(2012) Thomas Dörner et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy

(2012) Maria A. Lopez-Olivo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients

(2011) A Jamnitski et al.   ANNALS OF THE RHEUMATIC DISEASES

Biosimilars: a regulatory perspective from America

(2011) Jonathan Kay   ARTHRITIS RESEARCH & THERAPY

Impact of Product-Related Factors on Immunogenicity of Biotherapeutics

(2010) Satish Kumar Singh   JOURNAL OF PHARMACEUTICAL SCIENCES

Patients with Moderate Rheumatoid Arthritis (RA) Achieve Better Disease Activity States with Etanercept Treatment Than Patients with Severe RA

(2009) E. KEYSTONE et al.   JOURNAL OF RHEUMATOLOGY

Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study

(2008) B Combe et al.   ANNALS OF THE RHEUMATIC DISEASES

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

(2008) Paul Emery et al.   LANCET